First two years of reimbursed enzyme replacement therapy in the treatment of Fabry's disease in Poland

<p>There is dataset of collected information from&nbsp;seven largest academic centers in Katowice, Krak&oacute;w, Wrocław, Poznań, Gdańsk, Warszawa, and Ł&oacute;dź in Poland. The questionnaire included the following data: number of patients treated, number of patients qualified for ERT, and patient characteristics.&nbsp;</p> <p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>